Nicoletta B.
- Country
- Italy
- Department
- SC Oncoematologia Pediatrica
Research Overview
- Randomized Phase 3 Trial of Venetoclax Added to Fludarabine, High‑Dose Cytarabine, and Gemtuzumab Ozogamicin in Children with Relapsed Acute Myeloid Leukemia
- Phase I/II Evaluation of Inotuzumab Ozogamicin Monotherapy and Combined Chemotherapy in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia
- Phase 1/2 Study of Quizartinib in Combination with Chemotherapy in Pediatric and Young Adult Patients with FLT3-ITD Mutated Relapsed/Refractory Acute Myeloid Leukemia
Data & Insights
Has run more than one trial at 22 of 62 partner sites.
Specializations
Hematologic Malignancies
The investigator specializes in treating blood cancers, with particular focus on acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) in pediatric and young adult populations.
- Novel therapeutic approaches for AML treatment
- CD22-positive relapsed/refractory ALL management
- Targeted therapies in chronic myeloid leukemia
Their research encompasses innovative treatment strategies including targeted therapies and combination approaches for challenging blood cancers.
Pediatric Oncology
This investigator focuses on developing treatments specifically for children and young adults with various forms of cancer, including high-grade gliomas and blood malignancies.
- Pediatric-specific dosing protocols
- Age-adapted treatment strategies
- Novel combination therapies
Their work emphasizes therapeutic approaches tailored to young patients' unique needs and characteristics.
Neuro-Oncology
The investigator conducts research in brain cancer treatment, particularly focusing on high-grade glioma management in younger populations.
- Post-radiotherapy treatment optimization
- Combination therapy approaches
- Novel therapeutic strategies
Their research explores innovative treatment combinations to improve outcomes in challenging brain tumors.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.